Clinical Trial Update: Study of Docetaxel, Capecitabine and Oxaliplatin in Advanced Stomach Cancer [Phase 1]

View source ↗

Summary

Phase 1 study update evaluating a combination of docetaxel, capecitabine, and oxaliplatin in advanced stomach cancer has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stomach Cancer

Drugs mentioned

• Docetaxel, Capecitabine and Oxaliplatin

Snippet

Sponsor: Asan Medical Center | Conditions: Stomach Cancer | Phase 1 | Status: COMPLETED | Results posted: 2015-07-28